Twist Bioscience Corp diskutieren
Twist Bioscience Corp
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Aktie / Pharmazeutika / Small Cap /
74,94 €
-1,60 %
Twist Bioscience Co. (NASDAQ: TWST) had its "outperform" rating re-affirmed by analysts at Scotiabank.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $58.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Robert W. Baird from $54.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at JPMorgan Chase & Co. from $40.00 to $33.00. They now have an "underweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $50.00 price target on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $55.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Der Beitrag wird untersucht
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Evercore ISI from $46.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its price target raised by Guggenheim from $50.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Ratings data for TWST provided by MarketBeat
Neueste Beiträge
Roth_Mkm in Discuss Vicor Corp.